GURUFOCUS.COM » STOCK LIST » Industrials » Conglomerates » Medical Ikkou Group Co Ltd (TSE:3353) » Definitions » YoY EBITDA Growth

Medical Ikkou Group Co (TSE:3353) YoY EBITDA Growth : 32.99% (As of Nov. 2023)


View and export this data going back to 2004. Start your Free Trial

What is Medical Ikkou Group Co YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Medical Ikkou Group Co's YoY EBITDA Growth for the quarter that ended in Nov. 2023 was 32.99%.

Medical Ikkou Group Co's EBITDA per Share for the three months ended in Nov. 2023 was 円136.56.


Medical Ikkou Group Co YoY EBITDA Growth Historical Data

The historical data trend for Medical Ikkou Group Co's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medical Ikkou Group Co YoY EBITDA Growth Chart

Medical Ikkou Group Co Annual Data
Trend Feb14 Feb15 Feb16 Feb17 Feb18 Feb19 Feb20 Feb21 Feb22 Feb23
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only -25.54 4.17 9.25 3.56 -8.30

Medical Ikkou Group Co Quarterly Data
Feb19 May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -6.82 5.87 11.43 35.96 32.99

Medical Ikkou Group Co YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Medical Ikkou Group Co's YoY EBITDA Growth for the fiscal year that ended in Feb. 2023 is calculated as:

YoY EBITDA Growth (A: Feb. 2023 )
=(EBITDA per Share (A: Feb. 2023 )-EBITDA per Share (A: Feb. 2022 ))/ | EBITDA per Share (A: Feb. 2022 ) |
=(587.211-640.362)/ | 640.362 |
=-8.30 %

Medical Ikkou Group Co's YoY EBITDA Growth for the quarter that ended in Nov. 2023 is calculated as:

YoY EBITDA Growth (Q: Nov. 2023 )
=(EBITDA per Share (Q: Nov. 2023 )-EBITDA per Share (Q: Nov. 2022 )) / | EBITDA per Share (Q: Nov. 2022 )) |
=(136.56-102.686)/ | 102.686 |
=32.99 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Medical Ikkou Group Co YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Medical Ikkou Group Co's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Medical Ikkou Group Co (TSE:3353) Business Description

Traded in Other Exchanges
N/A
Address
501 62 Fujikata, Mie Prefecture, Tsu, JPN, 514-0815
Medical Ikkou Group Co Ltd is engaged in Dispensing pharmacy business, healthcare business, pharmaceutical wholesale business, real estate business, and investment business.

Medical Ikkou Group Co (TSE:3353) Headlines

No Headlines